Journal Article Summary
The article investigates the effectiveness of mirtazapine compared to megestrol in treating anorexia-cachexia syndrome in patients with advanced cancer. This syndrome is characterized by significant weight loss and reduced appetite, which can severely impact the quality of life and treatment outcomes for cancer patients. Given the lack of FDA-approved treatments specifically for this condition, understanding the potential benefits of these medications is crucial for improving patient care and managing symptoms associated with advanced cancer.
In this randomized, double-blind, controlled trial, 52 patients with advanced cancer and anorexia-cachexia syndrome were assigned to receive either mirtazapine (30 mg/day) or megestrol (320 mg/day) for eight weeks. The study found that weight gain occurred in 52% of participants taking megestrol compared to 38% in the mirtazapine group after four weeks. Additionally, appetite improved in 92% of the megestrol group versus 56% in the mirtazapine group after eight weeks, indicating that megestrol was more effective in enhancing both weight and appetite.
However, the study has limitations, including a small sample size and the fact that it was conducted at a single center, which may affect the generalizability of the findings. Patients should be aware that while megestrol showed better results, both medications had adverse effects, with mirtazapine associated with higher rates of nausea and drowsiness. It is important for patients and caregivers to discuss these findings and any concerns about treatment options with their healthcare providers to make informed decisions tailored to individual health needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Almeida Olga Laura Sena, Ferriolli Eduardo, Taveira Roberta Cristina Cintra, Rosenburg Meire Gallo, Campanari Daniela Dalpubel, da Cruz Alves Natália Maira, Pfrimer Karina, Rapatoni Liane, et al.. Mirtazapine versus Megestrol in the Treatment of Anorexia–Cachexia Syndrome in Patients with Advanced Cancer: A Randomized, Double-Blind, Controlled Phase II Clinical Trial. Cancers 2023. DOI: 10.3390/cancers15143588. PMID: 37509249. PMCID: PMC10377007.
Featured Pill Pals Product
Mirtazapine 15 mg Tablets --- 30 Count --- Generic for Remeron --- Rising Pharma
Mirtazapine 15 mg Tablets — 30 Count — Generic for Remeron — Rising Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
